Efficacy and Safety of LigaSure in Breast Surgery With Axillary Lymph Node Dissection in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
Muhammad Imran, Mansab Ali, Tungki Pratama Umar, Shujaat Ali, Saba Khalil, Hamza Irfan, Aiman Muhammad, Amna Javed, Fatima Shahzadi, Seemab Ara, Amir Usman, Ubaid Khan
{"title":"Efficacy and Safety of LigaSure in Breast Surgery With Axillary Lymph Node Dissection in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.","authors":"Muhammad Imran, Mansab Ali, Tungki Pratama Umar, Shujaat Ali, Saba Khalil, Hamza Irfan, Aiman Muhammad, Amna Javed, Fatima Shahzadi, Seemab Ara, Amir Usman, Ubaid Khan","doi":"10.1177/15533506241305892","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Conventional axillary lymph node dissection (ALND) is associated with significant post-operative morbidity in patients undergoing breast surgery due to increased lymphatic leakage. LigaSure, an electrothermal bipolar vessel sealing system, provides better closure of the leakage. This study aims to compare the efficacy and safety of LigaSure against conventional techniques in patients with breast cancer underwent ALND and breast surgery.</p><p><strong>Methods: </strong>We conducted a comprehensive search across the databases to identify relevant studies. The search results were imported into Covidence for article eligibility screening, and all relevant outcomes data were synthesized using odd ratios (ORs) or standardized mean differences (SMDs) with 95% confidence intervals (CIs) in meta-analysis models using RevMan 5.4.</p><p><strong>Results: </strong>Twelve studies with the total of 895 patients (LigaSure = 441; Conventional technique = 454) with breast cancer underwent breast surgery with ALND were included. LigaSure was associated with significantly lower post-operative drain volume (SMD: -0.39, 95% CI [-0.53, -0.24], <i>P</i> < 0.00001), shortened duration of drain (SMD: -0.51, 95% CI [-0.67, -0.34], <i>P</i> < 0.00001), and reduced hospital stay length (SMD: -0.57, 95% CI [-0.96, -0.18], <i>P</i> = 0.004) compared to conventional techniques. However, no difference observed in total operation time, intra-operative blood loss, seroma related outcomes and post-operative complications between the two groups.</p><p><strong>Conclusion: </strong>LigaSure significantly reduced the lymphorrhea, duration of drain and hospital stay, however, it did not prove be effective in seroma-related outcomes.</p>","PeriodicalId":22095,"journal":{"name":"Surgical Innovation","volume":" ","pages":"15533506241305892"},"PeriodicalIF":1.2000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Innovation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15533506241305892","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Conventional axillary lymph node dissection (ALND) is associated with significant post-operative morbidity in patients undergoing breast surgery due to increased lymphatic leakage. LigaSure, an electrothermal bipolar vessel sealing system, provides better closure of the leakage. This study aims to compare the efficacy and safety of LigaSure against conventional techniques in patients with breast cancer underwent ALND and breast surgery.
Methods: We conducted a comprehensive search across the databases to identify relevant studies. The search results were imported into Covidence for article eligibility screening, and all relevant outcomes data were synthesized using odd ratios (ORs) or standardized mean differences (SMDs) with 95% confidence intervals (CIs) in meta-analysis models using RevMan 5.4.
Results: Twelve studies with the total of 895 patients (LigaSure = 441; Conventional technique = 454) with breast cancer underwent breast surgery with ALND were included. LigaSure was associated with significantly lower post-operative drain volume (SMD: -0.39, 95% CI [-0.53, -0.24], P < 0.00001), shortened duration of drain (SMD: -0.51, 95% CI [-0.67, -0.34], P < 0.00001), and reduced hospital stay length (SMD: -0.57, 95% CI [-0.96, -0.18], P = 0.004) compared to conventional techniques. However, no difference observed in total operation time, intra-operative blood loss, seroma related outcomes and post-operative complications between the two groups.
Conclusion: LigaSure significantly reduced the lymphorrhea, duration of drain and hospital stay, however, it did not prove be effective in seroma-related outcomes.
背景:常规腋窝淋巴结清扫术(ALND)与乳房手术患者术后发病率显著相关,原因是淋巴渗漏增加。LigaSure是一种电热双极密封系统,可以更好地封闭泄漏。本研究旨在比较LigaSure与传统技术在乳腺癌ALND和乳房手术患者中的疗效和安全性。方法:我们在数据库中进行了全面的检索,以确定相关研究。将检索结果导入covid - ence进行文章资格筛选,并使用RevMan 5.4在meta分析模型中使用奇比(or)或95%置信区间(ci)的标准化平均差(SMDs)综合所有相关结果数据。结果:12项研究共纳入895例患者(LigaSure = 441;纳入454例常规技术乳腺癌患者,并行乳房手术合并ALND。与传统技术相比,LigaSure术后引流量显著降低(SMD: -0.39, 95% CI [-0.53, -0.24], P < 0.00001),引流时间缩短(SMD: -0.51, 95% CI [-0.67, -0.34], P < 0.00001),住院时间缩短(SMD: -0.57, 95% CI [-0.96, -0.18], P = 0.004)。两组手术总时间、术中出血量、血肿相关结局及术后并发症均无差异。结论:LigaSure可显著减少淋巴漏、引流时间和住院时间,但对血清相关结局无效。
期刊介绍:
Surgical Innovation (SRI) is a peer-reviewed bi-monthly journal focusing on minimally invasive surgical techniques, new instruments such as laparoscopes and endoscopes, and new technologies. SRI prepares surgeons to think and work in "the operating room of the future" through learning new techniques, understanding and adapting to new technologies, maintaining surgical competencies, and applying surgical outcomes data to their practices. This journal is a member of the Committee on Publication Ethics (COPE).